Nexien BioPharma and Ivy League University Medical School Collaborate On Pre-Clinical Cannabinoid Studies
Nexien Biopharma will investigate advanced cannabinoid-based formulations for acute treatment of convulsive disorders with an Ivy League Medical School. Nexien Biopharma (OTCQB:NXEN) DENVER, COLORADO, UNITED STATES, November 28, 2018 /EINPresswire.com/ …